These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 22584081)

  • 1. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
    Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
    Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.
    Long MD; Herfarth HH; Pipkin CA; Porter CQ; Sandler RS; Kappelman MD
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):268-74. PubMed ID: 20005977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of pneumonia among patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.
    Scott FI; Mamtani R; Brensinger CM; Haynes K; Chiesa-Fuxench ZC; Zhang J; Chen L; Xie F; Yun H; Osterman MT; Beukelman T; Margolis DJ; Curtis JR; Lewis JD
    JAMA Dermatol; 2016 Feb; 152(2):164-72. PubMed ID: 26510126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
    Peyrin-Biroulet L; Khosrotehrani K; Carrat F; Bouvier AM; Chevaux JB; Simon T; Carbonnel F; Colombel JF; Dupas JL; Godeberge P; Hugot JP; Lémann M; Nahon S; Sabaté JM; Tucat G; Beaugerie L;
    Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
    Ariyaratnam J; Subramanian V
    Am J Gastroenterol; 2014 Feb; 109(2):163-9. PubMed ID: 24419479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines.
    Bahi M; Walmsley RS; Gray AR; Young D; Hobbs CE; Aluzaite K; Schultz M
    J Gastroenterol Hepatol; 2018 May; 33(5):1047-1052. PubMed ID: 29105142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.
    Singh H; Nugent Z; Demers AA; Bernstein CN
    Gastroenterology; 2011 Nov; 141(5):1612-20. PubMed ID: 21806945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature.
    Hagen JW; Pugliano-Mauro MA
    Dermatol Surg; 2018 Apr; 44(4):469-480. PubMed ID: 29315147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
    Narous M; Nugent Z; Singh H; Bernstein CN
    Inflamm Bowel Dis; 2023 Jul; 29(7):1047-1056. PubMed ID: 35929649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of skin cancers in thiopurines-treated and thiopurines-untreated patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Huang SZ; Liu ZC; Liao WX; Wei JX; Huang XW; Yang C; Xia YH; Li L; Ye C; Dai SX
    J Gastroenterol Hepatol; 2019 Mar; 34(3):507-516. PubMed ID: 30393891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System.
    McKenna MR; Stobaugh DJ; Deepak P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):267-71. PubMed ID: 25267954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
    Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
    Abbas AM; Almukhtar RM; Loftus EV; Lichtenstein GR; Khan N
    Am J Gastroenterol; 2014 Nov; 109(11):1781-93. PubMed ID: 25244964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Lymphoma, Colorectal and Skin Cancer in Patients with IBD Treated with Immunomodulators and Biologics: A Quebec Claims Database Study.
    Kopylov U; Vutcovici M; Kezouh A; Seidman E; Bitton A; Afif W
    Inflamm Bowel Dis; 2015 Aug; 21(8):1847-53. PubMed ID: 25993693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists.
    Townsend CM; Khanna R; Wilson AS
    Dig Dis Sci; 2021 Dec; 66(12):4436-4440. PubMed ID: 33428042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.
    Clowry J; Sheridan J; Healy R; Deady S; Keegan D; Byrne K; Cullen G; Mulcahy H; Comber H; Parnell AC; Doherty G; Lally A
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):978-985. PubMed ID: 28045204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.
    Tseng HW; Shiue YL; Tsai KW; Huang WC; Tang PL; Lam HC
    Medicine (Baltimore); 2016 Jun; 95(26):e4070. PubMed ID: 27368048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis.
    Kobayashi T; Uda A; Udagawa E; Hibi T
    J Crohns Colitis; 2020 Jun; 14(5):617-623. PubMed ID: 31867632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.